Evaluation of Relationship Between Preoperative Fibrinogen/Albumin Ratio and Morbidity After Hip Fracture Operations
1 other identifier
observational
108
1 country
1
Brief Summary
Due to the aging of populations, hip fracture operations are increasing from year to year. This operations have many complications also high morbidity and the mortality. Population of this study is oldest old age patients who will have an operation because of hip fracture. The primary outcome of this study is evaluation of relationship between preoperative fibrinogen/albumin ratio and the morbidity after hip fracture operations. The secondary outcomes of this study is evaluation of relationships between fibrinogen/albumin ratio and mortality, length of stay in ICU, length of stay in hospital, postoperative complications, blood product consumption. The study will be completed after the records of preoperative, intraoperative data and the data of the first 30 days postoperatively in this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 11, 2022
CompletedFirst Posted
Study publicly available on registry
March 9, 2022
CompletedStudy Start
First participant enrolled
March 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedMarch 2, 2023
March 1, 2023
11 months
February 11, 2022
March 1, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Morbidity
Age Adjusted Charlson Comorbidity Index will be calculated for morbidity estimation. This score predicts the ten-year mortality for a patient who may have a range of comorbid conditions. The minimum score is 4 for oldest old patients. The maximum score is 34. Higher scores mean a worse outcome.
Preoperative (before induction of anesthesia)
Secondary Outcomes (7)
Nottingham Hip Fracture Score
Preoperative (before induction of anesthesia)
Clinical Frailty Scale Score
Preoperative (before induction of anesthesia)
Mortality
Up to 30 days
Length of stay in ICU
Up to 30 days
Length of stay in hospital
Up to 30 days
- +2 more secondary outcomes
Eligibility Criteria
Patients over 85 years of age who will undergo hip fracture surgery, whose preoperative albumin/fibrinogen ratio is checked
You may qualify if:
- ≥85 years old patients
- Primary operation
- Undergoing hip fracture surgery
- Receiving consent from patients or guardians that they accept regional anesthesia
- Not having active infection
- American Society of Anesthesiologists (ASA) 1-4
- BMI\< 40 kg/m²
You may not qualify if:
- Refusal regional anesthesia
- Infection on regional anesthesia application area
- Infection in the central nervous system
- Coagulopathy
- Known allergy against local anesthetics
- Severe hepatic insufficiency
- Haematologic disease
- Rheumatological disease
- Autoimmune disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul University
Istanbul, Fatih, 34093, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emine Dizem Sunal, MD
Istanbul University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, M.D.
Study Record Dates
First Submitted
February 11, 2022
First Posted
March 9, 2022
Study Start
March 30, 2022
Primary Completion
February 21, 2023
Study Completion
March 1, 2023
Last Updated
March 2, 2023
Record last verified: 2023-03